|
CAPZA1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.639000E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.793200E-04 |
| Normal-vs-Stage2 |
9.455600E-01 |
| Normal-vs-Stage3 |
7.222400E-02 |
| Normal-vs-Stage4 |
2.612100E-02 |
| Stage1-vs-Stage2 |
2.416800E-03 |
| Stage1-vs-Stage3 |
1.522190E-01 |
| Stage1-vs-Stage4 |
4.880800E-01 |
| Stage2-vs-Stage3 |
1.040610E-01 |
| Stage2-vs-Stage4 |
4.415900E-02 |
| Stage3-vs-Stage4 |
6.764000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.299300E-03 |
| Normal-vs-AfricanAmerican |
1.199960E-02 |
| Normal-vs-Asian |
1.644040E-02 |
| Caucasian-vs-AfricanAmerican |
5.301600E-01 |
| Caucasian-vs-Asian |
9.987600E-01 |
| AfricanAmerican-vs-Asian |
5.439000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.454450E-02 |
| Normal-vs-Female |
7.597200E-03 |
| Male-vs-Female |
9.904800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.409500E-04 |
| Normal-vs-Age(41-60Yrs) |
1.265200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.460600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.998300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.627800E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.209650E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.306800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.488000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.208200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.997800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.494200E-01 |
| Classical-VS-Follicular |
2.1490999999596E-06 |
| Classical-VS-Other |
2.048400E-01 |
| Classical-VS-Normal |
1.551690E-04 |
| Tall-VS-Follicular |
9.055300E-03 |
| Tall-VS-Other |
1.153630E-01 |
| Tall-VS-Normal |
1.273810E-02 |
| Follicular-VS-Other |
7.736800E-01 |
| Follicular-VS-Normal |
9.787200E-01 |
| Other-VS-Normal |
7.407600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.552760E-01 |
| Normal-vs-N1 |
5.694400E-02 |
| N0-vs-N1 |
3.995800E-01 |
|
|
